RiverPark Advisors »

Mirum Pharmaceuticals shares owned by RiverPark Advisors

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by RiverPark Advisors from 13F filings

Historical chart of RiverPark Advisors investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by RiverPark Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by RiverPark Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $121k 1.7k 73.31

More positions owned by RiverPark Advisors

Q2 HLDGS Note 0.125%11/1 (Principal)
Dayforce Note 0.250% 3/1 (Principal)
Airbnb Note 3/1 (Principal)
Magnite Note 0.250% 3/1 (Principal)
Verint Systems Note 0.250% 4/1 (Principal)
Redfin Corp Note 10/1 (Principal)
Microsoft Corporation (MSFT)
Apple (AAPL)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Taiwan Semiconductor Manufacturing Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Guess Note 3.750% 4/1 (Principal)
Visa Com Cl A (V)

View all positions for RiverPark Advisors

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
Henderson Group
BlackRock
Vanguard Group
Eventide Asset Management
BVF
State Street Corporation
Novo A/S
Tang Capital Management
Citadel Advisors
Geode Capital Management
ClearBridge Advisors
D. E. Shaw & Co
Polar Capital Holdings
Wellington Management Company

View all funds holding Mirum Pharmaceuticals